Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Structural basis for cisplatin DNA damage tolerance by human polymerase η during cancer chemotherapy

Abstract

A major clinical problem in the use of cisplatin to treat cancers is tumor resistance. DNA polymerase η (Pol-η) is a crucial polymerase that allows cancer cells to cope with the cisplatin–DNA adducts that are formed during chemotherapy. We present here a structure of human Pol-η inserting deoxycytidine triphosphate (dCTP) opposite a cisplatin intrastrand cross-link (PtGpG). We show that the specificity of human Pol-η for PtGpG derives from an active site that is open to permit Watson-Crick geometry of the nascent PtGpG-dCTP base pair and to accommodate the lesion without steric hindrance. This specificity is augmented by the residues Gln38 and Ser62, which interact with PtGpG, and Arg61, which interacts with the incoming dCTP. Collectively, the structure provides a basis for understanding how Pol-η in human cells can tolerate the DNA damage caused by cisplatin chemotherapy and offers a framework for the design of inhibitors in cancer therapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Human Pol-η–DNA ternary complexes.
Figure 2: Comparison of the human Pol-η–PtGpG ternary complex with the human Pol-η–thymine–thymine dimer and human Pol-κ–DNA complexes.
Figure 3: Close-up views of the active site regions.

Similar content being viewed by others

Accession codes

Primary accessions

Protein Data Bank

Referenced accessions

Protein Data Bank

References

  1. Kelland, L. The resurgence of platinum-based cancer chemotherapy. Nat. Rev. Cancer 7, 573–584 (2007).

    Article  CAS  Google Scholar 

  2. Wang, D. & Lippard, S.J. Cellular processing of platinum anticancer drugs. Nat. Rev. Drug Discov. 4, 307–320 (2005).

    Article  CAS  Google Scholar 

  3. Kartalou, M. & Essigmann, J.M. Mechanisms of resistance to cisplatin. Mutat. Res. 478, 23–43 (2001).

    Article  CAS  Google Scholar 

  4. Lord, C.J. & Ashworth, A. The DNA damage response and cancer therapy. Nature 481, 287–294 (2012).

    Article  CAS  Google Scholar 

  5. Prakash, S., Johnson, R.E. & Prakash, L. Eukaryotic translesion synthesis DNA polymerases: specificity of structure and function. Annu. Rev. Biochem. 74, 317–353 (2005).

    Article  CAS  Google Scholar 

  6. Johnson, R.E., Prakash, S. & Prakash, L. Efficient bypass of a thymine-thymine dimer by yeast DNA polymerase, Polη. Science 283, 1001–1004 (1999).

    Article  CAS  Google Scholar 

  7. Masutani, C. et al. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase η. Nature 399, 700–704 (1999).

    Article  CAS  Google Scholar 

  8. Biertümpfel, C. et al. Structure and mechanism of human DNA polymerase η. Nature 465, 1044–1048 (2010).

    Article  Google Scholar 

  9. Silverstein, T.D. et al. Structural basis for the suppression of skin cancers by DNA polymerase η. Nature 465, 1039–1043 (2010).

    Article  CAS  Google Scholar 

  10. Vaisman, A., Masutani, C., Hanaoka, F. & Chaney, S.G. Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase η. Biochemistry 39, 4575–4580 (2000).

    Article  CAS  Google Scholar 

  11. Chen, Y.W., Cleaver, J.E., Hanaoka, F., Chang, C.F. & Chou, K.M. A novel role of DNA polymerase η in modulating cellular sensitivity to chemotherapeutic agents. Mol. Cancer Res. 4, 257–265 (2006).

    Article  CAS  Google Scholar 

  12. Bassett, E. et al. Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin adducts by human DNA polymerases β and η in vitro. Biochemistry 42, 14197–14206 (2003).

    Article  CAS  Google Scholar 

  13. Albertella, M.R., Green, C.M., Lehmann, A.R. & O'Connor, M.J. A role for polymerase η in the cellular tolerance to cisplatin-induced damage. Cancer Res. 65, 9799–9806 (2005).

    Article  CAS  Google Scholar 

  14. Ceppi, P. et al. Polymerase η mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy. Clin. Cancer Res. 15, 1039–1045 (2009).

    Article  CAS  Google Scholar 

  15. Alt, A. et al. Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase η. Science 318, 967–970 (2007).

    Article  CAS  Google Scholar 

  16. Gelasco, A. & Lippard, S.J. NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin. Biochemistry 37, 9230–9239 (1998).

    Article  CAS  Google Scholar 

  17. Davis, I.W. et al. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 35, W375–W383 (2007).

    Article  Google Scholar 

  18. Wong, J.H. et al. Structural insight into dynamic bypass of the major cisplatin-DNA adduct by Y-family polymerase Dpo4. EMBO J. 29, 2059–2069 (2010).

    Article  CAS  Google Scholar 

  19. Johnson, R.E., Washington, M.T., Haracska, L., Prakash, S. & Prakash, L. Eukaryotic polymerases ιι and ζ act sequentially to bypass DNA lesions. Nature 406, 1015–1019 (2000).

    Article  CAS  Google Scholar 

  20. Nair, D.T., Johnson, R.E., Prakash, L., Prakash, S. & Aggarwal, A.K. Rev1 employs a novel mechanism of DNA synthesis using a protein template. Science 309, 2219–2222 (2005).

    Article  CAS  Google Scholar 

  21. Lone, S. et al. Human DNA polymerase kappa encircles DNA: implications for mismatch extension and lesion bypass. Mol. Cell 25, 601–614 (2007).

    Article  CAS  Google Scholar 

  22. Johnson, R.E., Prakash, L. & Prakash, S. Yeast and human translesion DNA synthesis polymerases: expression, purification, and biochemical characterization. Methods Enzymol. 408, 390–407 (2006).

    Article  CAS  Google Scholar 

  23. McCoy, A.J., Grosse-Kunstleve, R.W., Storoni, L.C. & Read, R.J. Likelihood-enhanced fast translation functions. Acta Crystallogr. D Biol. Crystallogr. 61, 458–464 (2005).

    Article  Google Scholar 

  24. Winn, M.D., Murshudov, G.N. & Papiz, M.Z. Macromolecular TLS refinement in REFMAC at moderate resolutions. Methods Enzymol. 374, 300–321 (2003).

    Article  CAS  Google Scholar 

  25. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 (2004).

    Article  Google Scholar 

Download references

Acknowledgements

We thank the staff at Brookhaven National Laboratory (beamline X25) for facilitating X-ray data collection. We also thank G. Gerona-Navarro for assistance with HPLC. This work was supported by grants ES017767 and ES012411 from the US National Institutes of Health. A.U. was supported in part by US National Institutes of Health training grant T32 GM62754.

Author information

Authors and Affiliations

Authors

Contributions

A.K.A. and A.U. designed the experiments. A.U. determined the crystal structure. O.R. and A.U. prepared the cisplatin adduct. R.J. assisted in the crystallographic analysis. T.D.S. and S.L. assisted in DNA preparation. A.B. assisted in protein purification. J.R.C. and R.E.J. conducted the biochemical experiments. L.P. and S.P. guided the biochemical studies. A.K.A. wrote the manuscript with contributions from all of the authors.

Corresponding author

Correspondence to Aneel K Aggarwal.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–3 and Supplementary Table 1 (PDF 2332 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ummat, A., Rechkoblit, O., Jain, R. et al. Structural basis for cisplatin DNA damage tolerance by human polymerase η during cancer chemotherapy. Nat Struct Mol Biol 19, 628–632 (2012). https://doi.org/10.1038/nsmb.2295

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nsmb.2295

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing